Genetic and Biochemical Studies of Antibiotic Activity and Resistance
A section of Antibiotics (ISSN 2079-6382).
Section Information
An in-depth understanding of pathogenic microorganisms with respect to both genetics and biochemistry is important for the future treatment of infections. In this section, we welcome:
- Studies that use either genetics or biochemical assays to screen for novel antimicrobials
- Studies on host–pathogen interaction
- Studies on the horizontal spread of resistance
- Genomic studies aimed at identifying resistance and/or virulence genes
- Genomic-based epidemiological studies
We expect that these studies will contribute to the present or future treatment of infections or assist in intervening with the horizontal spread of resistance and/or virulence genes.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Pathogenic Escherichia coli: Virulence Mechanism and Antimicrobial Resistance (Deadline: 15 June 2024)
- Harnessing Genetics and Biochemistry to Discover Novel Antimicrobials (Deadline: 30 June 2024)
- Infectious Disease Testing and Pathogenic Bacterial Virulence Identification (Deadline: 30 June 2024)
- Genomic Analysis of Antimicrobial Drug-Resistant Bacteria (Deadline: 30 July 2024)
- Horizontal Gene Transfer (HGT): Key to the Multi-Antibiotic Resistance (MAR) Crisis (Deadline: 31 July 2024)
- Antimicrobial Resistance: What Can We Learn from Genomics? (Deadline: 31 August 2024)
- Genomic Insights: Exploring Antimicrobial Resistance, Virulence, and Epidemiology in Microbial Worlds (Deadline: 31 August 2024)
- Genetics and Antimicrobial Resistance in Pathogens of Hospital Importance (Deadline: 30 September 2024)
- Zoonotic Bacterial Infections: Genetic Studies and Antibiotic Resistance (Deadline: 31 October 2024)